Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
resistance of rectal cancer utilising tumour tissue and blood samples from rectal cancer patients attending national and international treatment centres. Importantly, this project will determine the potential
-
from rectal cancer patients attending national and international treatment centres. Importantly, this project will determine the potential role of complement components as novel predictors of response
-
appointments made directly to Senior Post-Doctoral research positions must have previous post-doctoral experience of at least 3 years. Please note that Garda vetting and/or an international police clearance
-
, security and systems research. CSIT is a large, research-focused school, participating in many major national and international research collaborations, and with extremely strong links to industry partners
-
-focused school, participating in many major national and international research collaborations, and with extremely strong links to industry partners. The School of Computer Science & Information Technology
-
Applications are invited for a temporary part-time (0.6FTE) post of a UCD Post-doctoral Research Fellow Level 2 within UCD School of Politics and International Relations. The School of Politics and
-
sustainable, circular economy. Encompassing 100+ researchers from twelve institutions in Ireland, along with International collaborators, BiOrbic is focused on training and developing the next generation of
-
the effectiveness of alcohol warning messages in Ireland. The project includes an interdisciplinary team including psychologists and statisticians, representatives from NGOs, and international collaborators. We
-
from over 30 industry partners. The Co-Centre is one of the first international centres to bring together researchers across Ireland, Northern Ireland and Great Britain at scale. The Co-Centre will
-
vetting and/or an international police clearance check may form part of the selection process. Project: Identification of a pharmacogenomic signature for anti-B cell precision therapy in membranous